{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:30:25Z","timestamp":1791833425099,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mce.2021.111419","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:30:46Z","timestamp":1628598646000},"page":"111419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells"],"prefix":"10.1016","volume":"537","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6611-8103","authenticated-orcid":false,"given":"Giada","family":"Marroncini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Anceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Fibbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Baldanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-2252","authenticated-orcid":false,"given":"Serena","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Polvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Peri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mce.2021.111419_bib1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trsl.2018.12.008","article-title":"Enhancing responsiveness of pancreatic cancer cells to gemcitabine treatment under hypoxia by heme oxygenase-1 inhibition","volume":"207","author":"Abdalla","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.mce.2021.111419_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110735","article-title":"Role of reactive oxygen species in cancer progression: molecular mechanisms and recent advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.mce.2021.111419_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00428-018-2298-0","article-title":"LIMK\/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance","volume":"472","author":"Aggelou","year":"2018","journal-title":"Virchows Arch."},{"key":"10.1016\/j.mce.2021.111419_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12885-015-1156-6","article-title":"Resolution of severe hyponatraemia is associated with improved survival in patients with cancer","volume":"15","author":"Balachandran","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.mce.2021.111419_bib5","doi-asserted-by":"crossref","first-page":"10864","DOI":"10.1074\/jbc.M110.155002","article-title":"Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss","volume":"286","author":"Barsony","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mce.2021.111419_bib6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s12017-013-8235-0","article-title":"Low extracellular sodium causes neuronal distress independently of reduced osmolality in an experimental model of chronic hyponatremia","volume":"15","author":"Benvenuti","year":"2013","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.mce.2021.111419_bib7","first-page":"3095","article-title":"Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support. care cancer off","volume":"23","author":"Berardi","year":"2015","journal-title":"J. Multinatl. Assoc. Support. Care Canc"},{"key":"10.1016\/j.mce.2021.111419_bib8","first-page":"621","article-title":"Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma. Support. care cancer off","volume":"23","author":"Berardi","year":"2015","journal-title":"J. Multinatl. Assoc. Support. Care Canc"},{"key":"10.1016\/j.mce.2021.111419_bib9","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919877725","article-title":"Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study","volume":"11","author":"Berardi","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.mce.2021.111419_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.critrevonc.2016.03.010","article-title":"Hyponatremia in cancer patients: time for a new approach","volume":"102","author":"Berardi","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.mce.2021.111419_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152079","article-title":"Risk of hyponatraemia in cancer patients treated with targeted therapies: a systematic review and meta-analysis of clinical trials","volume":"11","author":"Berardi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111419_bib12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2021.111419_bib13","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/cen.13315","article-title":"A systematic review of known interventions for the treatment of chronic nonhypovolaemic hypotonic hyponatraemia and a meta-analysis of the vaptans","volume":"86","author":"Bhandari","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.mce.2021.111419_bib14","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-016-2610-9","article-title":"The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients","volume":"16","author":"Castillo","year":"2016","journal-title":"BMC Canc."},{"key":"10.1016\/j.mce.2021.111419_bib15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2215\/CJN.10101110","article-title":"Mortality and serum sodium: do patients die from or with hyponatremia?","volume":"6","author":"Chawla","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2021.111419_bib16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.amjmed.2016.03.007","article-title":"The economic burden of hyponatremia: systematic review and meta-analysis","volume":"129","author":"Corona","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.mce.2021.111419_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080451","article-title":"Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis","volume":"8","author":"Corona","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111419_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124105","article-title":"Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis","volume":"10","author":"Corona","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.mce.2021.111419_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.ajkd.2011.08.029","article-title":"Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes","volume":"59","author":"Doshi","year":"2012","journal-title":"Am. J. kidney Dis. Off. J. Natl. Kidney Found."},{"key":"10.1016\/j.mce.2021.111419_bib20","doi-asserted-by":"crossref","first-page":"E6603","DOI":"10.1073\/pnas.1706011114","article-title":"Rho-associated kinase is a therapeutic target in neuroblastoma","volume":"114","author":"Dyberg","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.mce.2021.111419_bib21","article-title":"Prognostic impact of hyponatraemia in patients with colorectal cancer","author":"Farid","year":"2015","journal-title":"Color. Dis. Off. J. Assoc. Coloproctology Gt. Britain Irel."},{"key":"10.1016\/j.mce.2021.111419_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49601-3","article-title":"Weighing the prognostic role of hyponatremia in hospitalized patients with metastatic solid tumors: the HYPNOSIS study","volume":"9","author":"Fuc\u00e0","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mce.2021.111419_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-42667-5_1","article-title":"Targeting ROS-mediated crosstalk between autophagy and apoptosis in cancer","volume":"1260","author":"Gao","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.mce.2021.111419_bib24","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2021.111419_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.2015.4","article-title":"Current treatment practice and outcomes. Report of the hyponatremia registry","volume":"88","author":"Greenberg","year":"2015","journal-title":"Kidney Int."},{"key":"10.1016\/j.mce.2021.111419_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000493245","article-title":"Hyponatremia in Oncology patients","volume":"52","author":"Groh\u00e9","year":"2019","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.mce.2021.111419_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.lungcan.2009.05.015","article-title":"The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period","volume":"68","author":"Hansen","year":"2010","journal-title":"Lung Canc."},{"key":"10.1016\/j.mce.2021.111419_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s12029-021-00587-0","article-title":"Importance of heme oxygenase-1 in gastrointestinal cancers: functions, inductions, regulations, and signaling","author":"Hemmati","year":"2021","journal-title":"J. Gastrointest. Canc."},{"key":"10.1016\/j.mce.2021.111419_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/EJE-15-0111","article-title":"Hyponatremia and mortality risk: a Danish cohort study of 279\u200a508 acutely hospitalized patients","volume":"173","author":"Holland-Bill","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.mce.2021.111419_bib30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bjc.6605563","article-title":"Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma","volume":"102","author":"Jeppesen","year":"2010","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.mce.2021.111419_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2021.111419_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mehy.2012.05.023","article-title":"Proposing the use of hyponatremia as a marker to help identify high risk individuals for lung cancer","volume":"79","author":"Kasi","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mce.2021.111419_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000127386","article-title":"Clinical outcome of gastric cancer patients with bone marrow metastases","volume":"73","author":"Kim","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.mce.2021.111419_bib34","first-page":"338","article-title":"The influence of serum sodium concentration on prognosis in resected non-small cell lung cancer","volume":"62","author":"Kobayashi","year":"2014","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.mce.2021.111419_bib35","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s12020-019-02135-0","article-title":"Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro","volume":"67","author":"Marroncini","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/j.mce.2021.111419_bib36","first-page":"5239","article-title":"The presence of a constitutively active phosphoinositide 3-kinase in small cell lung cancer cells mediates anchorage-independent proliferation via a protein kinase B and p70(s6k)-dependent pathway","volume":"58","author":"Moore","year":"1998","journal-title":"Canc. Res."},{"key":"10.1016\/j.mce.2021.111419_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00280-017-3392-8","article-title":"Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management","volume":"80","author":"Oronsky","year":"2017","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.mce.2021.111419_bib38","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2217\/pgs.15.122","article-title":"PTEN and PI3K\/AKT in non-small-cell lung cancer","volume":"16","author":"P\u00e9rez-Ram\u00edrez","year":"2015","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.mce.2021.111419_bib39","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/jc.2012-4082","article-title":"Clinical review: the use of vaptans in clinical endocrinology","volume":"98","author":"Peri","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.mce.2021.111419_bib40","first-page":"565","article-title":"[Is hyponatremia a prognostic marker of survival for lung cancer?]","volume":"65","author":"Petereit","year":"2011","journal-title":"Pneumologie"},{"key":"10.1016\/j.mce.2021.111419_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2466-13-55","article-title":"A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan","volume":"13","author":"Petereit","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.mce.2021.111419_bib42","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mce.2021.111419_bib43","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111419_bib44","first-page":"1678","article-title":"The incidence of hyponatraemia and its effect on the ECOG performance status among lung cancer patients","volume":"7","author":"Sengupta","year":"2013","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.mce.2021.111419_bib45","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4161\/cc.24699","article-title":"Dissecting the roles of ROCK isoforms in stress-induced cell detachment","volume":"12","author":"Shi","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.mce.2021.111419_bib46","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00228-012-1295-5","article-title":"Pharmacokinetics and pharmacodynamics of single-dose oral tolvaptan in fasted and non-fasted states in healthy Caucasian and Japanese male subjects","volume":"68","author":"Shoaf","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.mce.2021.111419_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41388-019-1059-0","article-title":"Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy","volume":"39","author":"Sinha","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.mce.2021.111419_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2796.1995.tb00907.x","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease","volume":"238","author":"S\u00f8rensen","year":"1995","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mce.2021.111419_bib49","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41467-018-04290-w","article-title":"Structural basis for cofilin binding and actin filament disassembly","volume":"9","author":"Tanaka","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mce.2021.111419_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.lungcan.2014.07.022","article-title":"Prognostic role of hyponatremia in 564 small cell lung cancer patients treated with topotecan","volume":"86","author":"Tiseo","year":"2014","journal-title":"Lung Canc."},{"key":"10.1016\/j.mce.2021.111419_bib51","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111419_bib52","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mce.2021.111419_bib53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.mce.2021.111419_bib54","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinternmed.2009.513","article-title":"Impact of hospital-associated hyponatremia on selected outcomes","volume":"170","author":"Wald","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.mce.2021.111419_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000455014","article-title":"Adverse renal effects of immune checkpoint inhibitors: a narrative review","volume":"45","author":"Wanchoo","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.mce.2021.111419_bib56","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1681\/ASN.2005121371","article-title":"Cytoprotective effects of hypoxia against cisplatin-induced tubular cell apoptosis: involvement of mitochondrial inhibition and p53 suppression","volume":"17","author":"Wang","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.mce.2021.111419_bib57","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.21037\/tlcr-20-1147","article-title":"A narrative review of progress in diagnosis and treatment of small cell lung cancer patients with hyponatremia","volume":"9","author":"Wu","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.mce.2021.111419_bib58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.bcp.2015.03.015","article-title":"Mechanisms of tolvaptan-induced toxicity in HepG2 cells","volume":"95","author":"Wu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mce.2021.111419_bib59","first-page":"2475","article-title":"AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon","volume":"7","author":"Zinda","year":"2001","journal-title":"Clin. Canc. Res."}],"container-title":["Molecular and Cellular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072100263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030372072100263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:18:29Z","timestamp":1759587509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030372072100263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":59,"alternative-id":["S030372072100263X"],"URL":"https:\/\/doi.org\/10.1016\/j.mce.2021.111419","relation":{},"ISSN":["0303-7207"],"issn-type":[{"value":"0303-7207","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low sodium and tolvaptan have opposite effects in human small cell lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mce.2021.111419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111419"}}